Phillip Andrew Dennis, Chief Medical Officer at NovaBridge Biosciences (NBP), sold 8,209 shares at $0.71 ($6K) on 2026-09-18, disclosed to the SEC on 2026-09-21.
Open-market sale of $6k NBP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.